LIPOPROTEIN DISORDER
Clinical trials for LIPOPROTEIN DISORDER explained in plain language.
Never miss a new study
Get alerted when new LIPOPROTEIN DISORDER trials appear
Sign up with your email to follow new studies for LIPOPROTEIN DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection targets hidden heart risk factor
Disease control Recruiting nowThis study is testing whether an experimental injection called Kylo-11 can safely lower high levels of lipoprotein(a), a fatty particle in the blood linked to heart disease. About 204 adults with existing heart disease and elevated lipoprotein(a) will receive either Kylo-11 or a …
Matched conditions: LIPOPROTEIN DISORDER
Phase: PHASE2 • Sponsor: Kylonova (Xiamen) Biopharma co., LTD. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial targets hidden heart risk factor
Disease control Recruiting nowThis study is testing an investigational drug called DII235 to see if it can safely lower high levels of lipoprotein(a), a fatty particle in the blood linked to heart disease. It will involve about 200 adults who have heart disease or type 2 diabetes and high lipoprotein(a) level…
Matched conditions: LIPOPROTEIN DISORDER
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC
-
Scientists track hidden heart risk factor in 300 people
Knowledge-focused Recruiting nowThis study aims to better understand how high levels of a specific blood fat called Lipoprotein(a), or Lp(a), affect the stiffness of arteries and the function of the heart over time. Researchers will observe 300 adults for one year, measuring artery health, heart function, and t…
Matched conditions: LIPOPROTEIN DISORDER
Sponsor: University of Athens • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC